Evidence map›Paper›PMID 38483986›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Structural transitions modulate the chaperone activities of Grp94.

Yaa S Amankwah, Yasmeen Fleifil, Erin Unruh, Preston Collins, Yi Wang, Katherine Vitou, Alison Bates, Ikponwmosa Obaseki, Meghana Sugoor, John Paul Alao and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Hsp90: Bringing it all together.Cell stress & chaperones · 2025
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yaa S AmankwahDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.ORCID 0009-0006-3132-6806
Yasmeen FleifilDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Erin UnruhDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Preston CollinsDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Yi WangPelotonia Institute for Immuno-Oncology, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH 43210.
Katherine VitouDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Alison BatesDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.ORCID 0009-0005-7313-0345
Ikponwmosa ObasekiDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.ORCID 0000-0003-2280-9209
Meghana SugoorDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
John Paul AlaoDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Robert M McCarrickDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Daniel T GewirthHauptman-Woodward Medical Research Institute, Buffalo, NY 14203.
Indra D SahuNatural Sciences Division, Campbellsville University, Campbellsville, KY 42718.
Zihai LiPelotonia Institute for Immuno-Oncology, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH 43210.ORCID 0000-0003-4603-927X
Gary A LoriganDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.
Andrea N KravatsDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056.ORCID 0000-0001-8930-0170
Miami University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USCampbellsville University · USHauptman-Woodward Medical Research Institute · US

Funding

EPR Spectroscopic Studies of Membrane Proteins-Diversity SupplementR35GM126935 · NIGMS · MIAMI UNIVERSITY OXFORD · PI GARY A LORIGAN · 2018 to 2026
$3.3M
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy SupplementR01CA262069 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2021 to 2025
$2.9M
Elucidating the Mechanistic Details of the Grp94 Molecular Chaperone through an Integrated Computational and Experimental ApproachR35GM146963 · NIGMS · MIAMI UNIVERSITY OXFORD · PI Andrea N Kravats · 2022 to 2026
$1.7M
NCI NIH HHS R01 CA262069NIGMS NIH HHS R35 GM126935NIGMS NIH HHS R35 GM146963
6 · The paper itself

Abstract

Hsp90s are ATP-dependent chaperones that collaborate with co-chaperones and Hsp70s to remodel client proteins. Grp94 is the ER Hsp90 homolog essential for folding multiple secretory and membrane proteins. Grp94 interacts with the ER Hsp70, BiP, although the collaboration of the ER chaperones in protein remodeling is not well understood. Grp94 undergoes large-scale conformational changes that are coupled to chaperone activity. Within Grp94, a region called the pre-N domain suppresses ATP hydrolysis and conformational transitions to the active chaperone conformation. In this work, we combined in vivo and in vitro functional assays and structural studies to characterize the chaperone mechanism of Grp94. We show that Grp94 directly collaborates with the BiP chaperone system to fold clients. Grp94's pre-N domain is not necessary for Grp94-client interactions. The folding of some Grp94 clients does not require direct interactions between Grp94 and BiP in vivo, suggesting that the canonical collaboration may not be a general chaperone mechanism for Grp94. The BiP co-chaperone DnaJB11 promotes the interaction between Grp94 and BiP, relieving the pre-N domain suppression of Grp94's ATP hydrolysis activity. In structural studies, we find that ATP binding by Grp94 alters the ATP lid conformation, while BiP binding stabilizes a partially closed Grp94 intermediate. Together, BiP and ATP push Grp94 into the active closed conformation for client folding. We also find that nucleotide binding reduces Grp94's affinity for clients, which is important for productive client folding. Alteration of client affinity by nucleotide binding may be a conserved chaperone mechanism for a subset of ER chaperones.

Indexed as

HSP70 Heat-Shock ProteinsProtein FoldingAdenosine TriphosphateHumansMembrane ProteinsMolecular ChaperonesNucleotidesAdenosine TriphosphateHSP70 Heat-Shock ProteinsMembrane ProteinsMolecular ChaperonesNucleotidesBiPDEERDnaJB11EPRGrp94

Identifiers

PMID38483986
PMCPMC10962938
OpenAlexW4392826592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.